ClinicalTrials.gg
CompletedNCT05926388Updated Dec 18, 2023

Video-Assisted Instruction in Type 2 Diabetes Patients

An interventional study of Video-assisted training in Education, Patient, sponsored by Izmir Bakircay University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-12-18.

Sponsored by Izmir Bakircay University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jan 2022, registered Jun 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of the study of examine the effect of video-assisted instruction on Type 2 diabetes patients' insulin treatment self-management and insulin administration skills. The research will be conducted as a single group pre-test post-test quasi-experimental study. The sample of the study will be consisted of 50 patients with Type 2 Diabetes. Before the training, the patients will be self-injected a dose of insulin. After giving verbal training, the patients will watch a video recording of insulin treatment and administration. The author will be evaluated the patients' insulin treatment self-management and insulin administration skills after the training.

Read the detailed description

The aim of the study of examine the effect of video-assisted instruction on Type 2 diabetes patients' insulin treatment self-management and insulin administration skills. The research will be conducted as a single group pre-test post-test quasi-experimental study. The sample of the study will be consisted of 50 patients with Type 2 Diabetes. Before the training, the patients will be self-injected a dose of insulin. After giving verbal training, the patients will watch a video recording of insulin treatment and administration. The author will be evaluated the patients' insulin treatment self-management and insulin administration skills after the training.

02

Conditions studied

  • Education, Patient

Keywords

  • self-management
  • Type 2 diabetes mellitus
  • video-assisted instruction
03

In context

Diabetes Mellitus, Type 2

9,590 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,332 are open to participants now.

This study's enrollment of 50 is below the median of 81 across 7,713 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Izmir Bakircay University is the lead sponsor of 75 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-65 years
  • No hearing or communication problems
  • Self-injecting insulin

Exclusion criteria

Exclusion Criteria

  • Health care professionals
  • Chronic complications
  • Pregnant
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Video-assisted training group

    The researcher will train the patients with video-assisted on insulin therapy and administration.

    Other: Video-assisted training

Interventions

  • OtherVideo-assisted training

    Patients will be given training on insulin therapy and management using lecture, question-answer, video and demonstration methods.

06

What researchers measure

Primary outcomes

  1. Insulin Treatment Self-Management Scale 1 (Questionnaire)

    Patients' self-injection practices will be evaluated.

    Time frame: Seven days after the training

  2. Insulin Treatment Self-Management Scale 2 (Questionnaire)

    Patients' self-injection practices will be evaluated.

    Time frame: Five weeks after the training

  3. Insulin Administration Observation Form 1

    The scale identifies knowledge and skill levels of patients.

    Time frame: Seven days after the training

  4. Insulin Administration Observation Form 2

    The scale identifies knowledge and skill levels of patients.

    Time frame: Five weeks after the training

07

Study locations

1 site
  • izmir Bakircay University
    Izmir, Menemen 35160, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05926388
Lead sponsor
Izmir Bakircay University
Responsible party
Elif Günay İsmailoğlu (Associate Professor, Izmir Bakircay University) — Principal investigator
First posted
Jul 3, 2023
Start date
Jan 10, 2022
Primary completion
May 10, 2022
Completion
Aug 10, 2023
Last update
Dec 18, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion